Es. Proc Natl Acad Sci USA 106:19114-19119. 56. Kutluay SB, Bieniasz PD
Es. Proc Natl Acad Sci USA 106:19114-19119. 56. Kutluay SB, Bieniasz PD: Analysis of the initiating events in HIV-1 particle assembly and PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/27488460 genome packaging. PLoS Pathogens 2010, 6: e1001200. 57. Lindwasser OW, Resh MD: Myristoylation as a target for inhibiting HIV assembly: unsaturated fatty acids block viral budding. Proc Natl Acad Sci USA 2002, 99:13037-13042. 58. Ganser-Pornillos BK, Cheng A, Yeager M: Structure of full-length HIV-1 CA: a model for the mature capsid lattice. Cell 2007, 131:70-79. 59. Ganser-Pornillos BK, von Schwedler UK, Stray KM, Aiken C, Sundquist WI: Assembly properties of the human immunodeficiency virus type 1 CA protein. J Virol 2004, 78:2545-2552. 60. Ganser-Pornillos BK, Yeager M, Sundquist WI: The structural biology of HIV assembly. Curr Opin Struct Biol 2008, 18:203-217. 61. Colgan J, Yuan HE, Franke EK, Luban J: Binding of the human immunodeficiency virus type 1 Gag polyprotein to cyclophilin A is62.63.64. 65. 66.67.68. 69.70. 71.72.73.74.75.76.77.78.79.80.81.82.83.mediated by the central region of capsid and requires Gag dimerization. J Virol 1996, 70:4299-4310. Dorfman T, Weimann A, Borsetti A, Walsh CT, G tlinger HG: Active-site residues of cyclophilin A are crucial for its incorporation into human immunodeficiency virus type 1 virions. J Virol 1997, 71:7110-7113. Zhao Y, Chen Y, Schutkowski M, Fischer G, Ke H: Cyclophilin A complexed with a fragment of HIV-1 gag protein: insights into HIV-1 infectious activity. Structure 1997, 5:139-146. Briant L, Gay B, Devaux C, Chazal N: HIV-1 assembly, release and maturation. WJA 2011, 1:111-130. Cimarelli A, Darlix J-L: Assembling the human immunodeficiency virus type 1. Cell Mol Life Sci 2002, 59:1166-1184. Darlix JL, Cristofari G, Rau M, P houx C, Berthoux L, Roques B: Nucleocapsid protein of human immunodeficiency virus as a model protein with chaperoning functions and as a target for antiviral drugs. Adv Pharmacol 2000, 48:345-372. Ma YM, Vogt VM: Rous sarcoma virus Gag protein-oligonucleotide interaction suggests a critical role for protein dimer BUdR msds formation in assembly. J Virol 2002, , 76: 5452-5462. Ma YM, Vogt VM: Nucleic acid binding-induced Gag dimerization in the assembly of Rous Sarcoma Virus particles in vitro. J Virol 2004, 78:52-60. Gamble TR, Yoo S, Vajdos FF, von Schwedler UK, Worthylake DK, Wang H, McCutcheon JP, Sundquist WI, Hill CP: Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science 1997, 278:849-853. Ganser BK, Li S, Klishko VY, Finch JT, Sundquist WI: Assembly and analysis of conical models for the HIV-1 core. Science 1999, 283:80-83. DaFonseca S, Blommaert A, Coric P, Hong SS, Bouaziz S, Boulanger P: The 3-O-(3′, 3′-dimethylsuccinyl) derivative of betulinic acid (DSB) inhibits the assembly of virus-like particles in HIV-1 Gag precursor-expressing cells. Antiviral Ther 2007, 12:1185-1203. Hong SS, Boulanger P: Self-assembly-defective dominant mutants of HIV1 Gag phenotypically expressed in baculovirus-infected cells. J Virol 1993, 67:2787-2798. Huvent I, Hong SS, Fournier C, Gay B, PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/28300835 Tournier J, Carriere C, Courcoul M, Vigne R, Spire B, Boulanger P: Interaction and co-encapsidation of HIV-1 Vif and Gag recombinant proteins. J Gen Virol 1998, 79:1069-1081. Royer M, Hong SS, Gay B, Cerutti M, Boulanger P: Expression and extracellular release of human immunodeficiency virus type 1 Gag precursors by recombinant baculovirus-infected cells. J Virol 1992, 66:3230-3235. Nangola S, Minard P, Tayapiwatana C: Apprai.
